Cite
MLA Citation
Trisha Wise-Draper et al.. “809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A859–A860. http://access.bl.uk/ark:/81055/vdc_100144730960.0x000006